The anti-tumor effect of CIK cells combined with paclitaxel against ovarian cancer SKOV-3 cells in vitro

徐梅,李丹,蒋敬庭,吴昌平,尹凤玲,成杰,刘洋,张蓓
DOI: https://doi.org/10.3781/j.issn.1000-7431.2014.07.003
2014-01-01
Tumori
Abstract:Objective: To investigate the anti-tumor effect of cytokine-induced killer (CIK) cells combined with paclitaxel against ovarian cancer SKOV-3 cells in vitro. Methods: Peripheral blood mononuclear cells of healthy volunteers were stimulated by different cytokines and induced into CIK cells (as effector cells). The phenotype of CIK cells after culture for 14 d was analyzed by flow cytometry (FCM). The apoptosis of SKOV-3 cells cultured with CIK cells’ supernatant for 24 and 48 h was analyzed by FCM. The proliferative inhibition rates of SKOV-3 cells after treatment with CIK cells with different effector-target ratios or different concentrations of paclitaxel and paclitaxel (2.5 μg/mL) in combination with CIK cells with different effector-target ratios (10︰1 or 20︰1) were detected by MTT assay. Results: The proportion of CD3+CD56+ cells in CIK cells was (35.43±2.38) % after culture for 14 d. The apoptosis rate of SKOV-3 cells after culture with CIK cells’ supernatant was higher than that of the control cells (without culture with CIK cells’ supernatant) (P < 0.01). The inhibition rate of SKOV-3 cells was increased with the increase in effector-target ratio of CIK cells and the concentration of paclitaxel as well as with the prolonged culture time (P < 0.05). The inhibition rate of SKOV-3 cells treated with combination of CIK and paclitaxel (2.5 μg/mL) for 48 h was higher than those treated with CIK and paclitaxel alone (both P < 0.01). Conclusion: CIK cells have strong anti-cancer activity against ovarian cancer SKOV-3 cells by inducing apoptosis. It can enhance the anti-tumour effect of paclitaxel against SKOV-3 cells when in combination with CIK cells. DOI:10.3781/j.issn.1000-7431.2014.07.003
What problem does this paper attempt to address?